You searched for merck | Global Autoimmune Institute

<img alt="" src="https://secure.hiss3lark.com/178938.png" style="display:none;" />

Get Involved

Help make a difference in the lives of those with autoimmune disease.

What is Autoimmune Disease?
- AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  Read Our Article
  Autoimmune diseases (AD) occur when the immune system attacks the body’s own healthy cells. There are 80-100 known autoimmune diseases and counting, affecting more than 14 million Americans.
  AUTOIMMUNE VS AUTOINFLAMMATORY DISEASE
  
  A Comparative Look
  
  Autoimmune disease (AD) and autoinflammatory disease (AIF) are two categories of illnesses that occur when the immune system mistakenly damages healthy cells. Although these inflammatory disorders share many commonalities, there are key features that make them unique.
  
  Read Our Article
Resources & Support
- FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  Get Our Guide
  Browse our resource lists and information via the links below.
  FREE RESOURCE
  
  Find Hope in Your Health Journey
  
  The Autoimmune & Chronic Illness Toolkit includes journal templates, resource lists, guidance for doctor appointments, tips on communication, and many more tools to support and empower you throughout your experience.
  
  Get Our Guide
Education & Research
- HIGHLIGHTED PARTNERSHIP
  
  GAI is proud to fund the Raising Celiac podcast from the Celiac Disease Program at Boston Children’s Hospital
  
  Each episode features education, awareness and research on celiac disease in connection with other autoimmune conditions, including expert interviews on how these autoimmune diseases co-exist.
  View Podcast
  We support autoimmune disease research, awareness, and education. We fund clinical research, scientific investigations, multidisciplinary medicine, and educational resources, including podcasts and webinars.
  HIGHLIGHTED PARTNERSHIP
  
  GAI is proud to fund the Raising Celiac podcast from the Celiac Disease Program at Boston Children’s Hospital
  
  Each episode features education, awareness and research on celiac disease in connection with other autoimmune conditions, including expert interviews on how these autoimmune diseases co-exist.
  
  View Podcast
About Us
- SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI's work, autoimmune risk factors, research advances, and more!
  Read Our Feature
  The Global Autoimmune Institute is empowering solutions in the diagnosis and treatment of autoimmune disease (AD) through research, education, and validation while supporting multidisciplinary approaches to wellness.
  SPREADING AWARENESS
  
  We were proud to sponsor Nature Magazine’s July 2021 Outlook on Autoimmune Disease
  
  Learn more about GAI’s work, autoimmune risk factors, research advances, and more!
  
  Read Our Feature
Search

Search results for all "merck" in COVID News & Research Updates As It Relates To Autoimmune Disease

UK Approves Merck’s COVID-19 Antiviral Pill

November 8, 2021 Last Thursday, the UK became the first country to approve an antiviral drug for COVID-19. Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is designed to stop SARS-CoV-2…
Final Analysis Caps Merck’s COVID-19 Antiviral Pill at 30% Efficacy

November 30, 2021 Last Friday, Merck released a final analysis of its clinical trial for molnupiravir, their COVID-19 antiviral pill. An interim analysis stated molnupiravir reduced the risk of hospitalization…
Merck Submits COVID Antiviral Pill for EUA

October 11, 2021 This morning, the pharmaceutical company Merck submitted an application for EUA of their COVID-19 oral antiviral pill. If accepted, this will become the first pill authorized by…
EMA Recommends Merck’s COVID-19 Antiviral Pill

November 23, 2021 Last Friday, the European Union’s drug regulator recommended the use of Merck’s COVID-19 antiviral pill, molnupiravir. Earlier this month, Britain became the first country to grant authorization….

1 2 >>